Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evonik Closes LACTEL Absorbable Polymers Acquisition - Medical Product Outsourcing

What are you searching for?

Sign in
Financial & Business

Evonik Closes LACTEL Absorbable Polymers Acquisition

LACTEL's biodegradable, PLGA-based polymers will be integrated into Evonik’s Health Care business.

By: Michael Barbella

Managing Editor, Rodman Media

Evonik has closed its previously announced acquisition of the LACTEL Absorbable Polymers product line from DURECT Corporation. All DURECT employees associated with the LACTEL business in Birmingham, Ala., accepted the offer to join Evonik in similar roles. 
 
“The acquisition of the LACTEL business will strengthen both our innovation growth field Healthcare Solutions and Evonik’s position as a globally leading CDMO for drug delivery solutions”, said Johann-Caspar Gammelin, head of the Nutrition & Care Division of Evonik. The acquisition of the LACTEL business marks a consequential step in the growth agenda of the life sciences division Nutrition & Care. 
 
The LACTEL business will complement Evonik’s own RESOMER line of polymers, both being among the most preferred brands of standard and custom PLGA polymers. Poly(lactide-co-glycolide) (PLG or PLGA) polymers are widely used as a functional excipient to control the release of parenteral drug products. They are also utilized to control the biodegradation of implantable medical devices across various orthopedic, cardiovascular, wound healing and other applications.
 
“The integration of the LACTEL business into Evonik’s market-leading portfolio of functional excipients, biomaterials and integrated CDMO services will strengthen our position as a preferred development partner and solutions provider,” said Thomas Riermeier, head of the Health Care business line. “By welcoming LACTEL and members of their team into the Evonik family, we look forward to providing customers with even greater platform versatility as well as other value-adding services.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters